BrightInsight provides the leading global regulated digital health platform for biopharma and medtech.
BrightInsight's medical-grade Internet of Things (IoT) platform is built under a Quality Management System to support and optimize regulated drugs, devices and software through integrated data and actionable insights to enable customers to drive increased patient adherence and engagement.
BrightInsight was founded in 2017 by Kal Patel, Ferry Tamtoro & Ben Lee and is based in San Jose, California, with its Europe headquarter based in Hägglingen, Switzerland.
BrightInsight's mission is to make digital health innovation easy for our customers through our end-to-end digital health capabilities and scalable, medical-grade platform.
The BrightInsight™ Platform uses software and services to capture, transmit and analyze data from CE-marked and FDA-regulated medical devices, combination products, apps and Software as a Medical Device, in compliance with security, privacy and regulatory requirements.
BrightInsight will also further integrate its platform into the broader healthcare ecosystem, including Electronic Health Records (EHRs), payers and disease management programs.
BrightInsight is backed by Insight Partners, New Leaf Venture Partners, Eclipse Ventures and others. The company raised $40M in Series B round on Juune 23, 2020. This brings BrightInsight's total funding to $65M to date.
BrightInsight Platform was selected as the "Best IoT Healthcare Platform" in the 2019 MedTech Breakthrough Awards, the "2018 Google Cloud Partner of the Year for Healthcare and Life Sciences," and was featured as the cover story for CIOReview Magazine's "20 Most Promising Biotech Solution Providers 2019.